Rappange, David R.; van Baal, Pieter H.M.; van Exel, N. … - In: PharmacoEconomics 26 (2008) 10, pp. 815-830
Which costs and benefits to consider in economic evaluations of healthcare interventions remains an area of much controversy. Unrelated medical costs in life-years gained is an important cost category that is normally ignored in economic evaluations, irrespective of the perspective chosen for...